Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)

CNY 63.1

(1.25%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 4.37 Billion 3.44 Billion 3.13 Billion 2.98 Billion 1.32 Billion 374.99 Million
Total Current Assets 2.9 Billion 2.28 Billion 2.37 Billion 2.67 Billion 985.83 Million 222.09 Million
Cash And Short Term Investments 2.28 Billion 2.03 Billion 2.24 Billion 2.59 Billion 946.98 Million 128.61 Million
Cash and Cash Equivalents 1.86 Billion 470.49 Million 615.35 Million 365.84 Million 392.58 Million 128.61 Million
Short Term Investments 419.59 Million 1.56 Billion 1.62 Billion 2.22 Billion 554.4 Million -
Net Receivables 289.23 Million 204.59 Million 53.43 Million 31.26 Million 30.16 Million 1.00
Inventory 62.94 Million 32.07 Million 20.79 Million 10.78 Million 252.13 Thousand 41.63 Thousand
Other Current Assets 273.96 Million 12.28 Million 60.4 Million 45.98 Million 8.43 Million 93.43 Million
Total Non-Current Assets 1.46 Billion 1.15 Billion 755.59 Million 307.7 Million 342.57 Million 152.9 Million
Net PPE 529.26 Million 539.93 Million 404.03 Million 206.88 Million 138.16 Million 131.07 Million
Good Will And Intangible Assets 66.49 Million 68.45 Million 67.29 Million 69.18 Million 68.35 Million 8.31 Million
Good Will - - - - - -
Intangible Assets 66.49 Million 68.45 Million 67.29 Million 69.18 Million 68.35 Million 8.31 Million
Long-Term Investments 186.38 Million -1.51 Billion -1.58 Billion 761.07 Thousand 110.81 Million -
Tax Assets 1.00 11.5 Million 1.62 Billion -761.07 Thousand -110.81 Million -
Other Non Current Assets 686.46 Million 2.05 Billion 243.79 Million 31.63 Million 136.06 Million 13.51 Million
Other Assets -0.00 - - - 1.00 1.00
Total Liabilities 394.21 Million 255.11 Million 156.99 Million 109.01 Million 144.02 Million 303.96 Million
Total Current Liabilities 390.03 Million 254.61 Million 156.11 Million 109.01 Million 143.66 Million 303.26 Million
Account Payables 53.45 Million 43.68 Million 32.3 Million 41.97 Million 17.91 Million 13.67 Million
Tax Payables 5.39 Million 33.63 Million 4.51 Million 3.33 Million 3.32 Million 30.88 Million
Short Term Debt 1.42 Million 1.65 Million 4.71 Million 8.32 Million 110 Million 125 Million
Deferred Revenue 5.39 Million 104.77 Thousand 176.73 Thousand -8.32 Million -94.25 Million 30.88 Million
Other Current Liabilities 329.74 Million 209.17 Million 118.91 Million 67.03 Million 109.99 Million 133.7 Million
Total Non Current Liabilities 4.18 Million 498 Thousand 876.16 Thousand 4.01 Million 360 Thousand 697.2 Thousand
Long-Term Debt 393.22 Thousand 300.59 Thousand 678.75 Thousand 3.89 Million - -
Deferred Revenue Non Current 1.00 - - - 360 Thousand 697.2 Thousand
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 3.65 Million 197.41 Thousand 197.41 Thousand 111.74 Thousand - -
Other Liabilities 1.00 1.00 1.00 -4.01 Million - -
Total Equity 3.98 Billion 3.18 Billion 2.97 Billion 2.87 Billion 1.18 Billion 71.03 Million
Stock Holders Equity 3.98 Billion 3.18 Billion 2.97 Billion 2.87 Billion 1.18 Billion 71.03 Million
Common Stock 450 Million 450 Million 450 Million 450 Million 360 Million 50 Million
Retained Earnings 229.02 Million -380.15 Million -510.67 Million -528.95 Million -218.43 Million -4.02 Million
Accumulated other comprehensive income 619.06 Million 433.03 Million 349.76 Million 272.81 Million 1.04 Billion 25.06 Million
Common Stock Equity 3.98 Billion 3.18 Billion 2.97 Billion 2.87 Billion 1.18 Billion 71.03 Million
Capital Lease Obligation 393.22 Thousand 300.59 Thousand 678.75 Thousand 3.89 Million - -
Total Investments 605.98 Million 52.72 Million 38.36 Million 2.22 Billion 554.4 Million -
Total Debt 1.82 Million 1.95 Million 5.39 Million 12.22 Million 110 Million 125 Million
Net Debt -1.86 Billion -468.53 Million -609.96 Million -353.62 Million -282.58 Million -3.61 Million

Balance Sheet Charts